{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:49:35Z","timestamp":1765295375542,"version":"3.40.3"},"publisher-location":"Cham","reference-count":12,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783031210532"},{"type":"electronic","value":"9783031210549"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-3-031-21054-9_1","type":"book-chapter","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T13:02:55Z","timestamp":1678971775000},"page":"1-18","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development"],"prefix":"10.1007","author":[{"given":"Sheldon H.","family":"Preskorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"1_CR1","volume-title":"Dementia praecox and paraphrenia","author":"E Kraepelin","year":"1915","unstructured":"Kraepelin E. In: Barclay RM, Robertson GM, editors. Dementia praecox and paraphrenia. Huntington NY: Krieger; 1915."},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neuropharm.2014.12.004","volume":"91","author":"C Lavedan","year":"2015","unstructured":"Lavedan C, Forsberg M, Gentile AJ. Tasimelteon: a selective and unique receptor binding profile. Neuropharmacology. 2015;91:142\u20137.","journal-title":"Neuropharmacology"},{"issue":"11","key":"1_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3928\/0048-5713-19901101-06","volume":"20","author":"SH Preskorn","year":"1990","unstructured":"Preskorn SH. The future and psychopharmacology: potentials and needs. Psychiatr Ann. 1990;20(11):625\u201333.","journal-title":"Psychiatr Ann"},{"issue":"5","key":"1_CR4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/01.pra.0000388628.44405.c0","volume":"16","author":"SH Preskorn","year":"2010","unstructured":"Preskorn SH. CNS drug development. Part I: the early period of CNS drugs. J Psychiatr Pract. 2010a;16(5):334\u20139.","journal-title":"J Psychiatr Pract"},{"issue":"6","key":"1_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/01.pra.0000390760.12204.99","volume":"16","author":"SH Preskorn","year":"2010","unstructured":"Preskorn SH. CNS drug development: part II: advances from the 1960s to the 1990s. J Psychiatr Pract. 2010b;16(6):413\u20135.","journal-title":"J Psychiatr Pract"},{"issue":"1","key":"1_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/01.pra.0000393844.48593.82","volume":"17","author":"SH Preskorn","year":"2011","unstructured":"Preskorn SH. CNS drug development: part III: future directions. J Psychiatr Pract. 2011;17(1):49\u201352.","journal-title":"J Psychiatr Pract"},{"issue":"6","key":"1_CR7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/01.pra.0000456594.66363.6f","volume":"20","author":"SH Preskorn","year":"2014","unstructured":"Preskorn SH. CNS drug development: lessons from the development of ondansetron, aprepitant, ramelteon, varenicline, lorcaserin, and suvorexant. Part I. J Psychiatr Pract. 2014;20(6):460\u20135.","journal-title":"J Psychiatr Pract"},{"issue":"1","key":"1_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/01.pra.0000460622.33300.64","volume":"21","author":"SH Preskorn","year":"2015","unstructured":"Preskorn SH. CNS drug development: lessons learned part 2. Symptoms, not syndromes as targets consistent with the NIMH research domain approach. J Psychiatr Pract. 2015;21(1):60\u20136.","journal-title":"J Psychiatr Pract"},{"issue":"5","key":"1_CR9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/PRA.0000000000000258","volume":"23","author":"S Preskorn","year":"2017","unstructured":"Preskorn S. Psychiatric and central nervous system drugs developed over the last decade: what are the implications for the field? J Psychiatr Pract. 2017a;23(5):352\u201360.","journal-title":"J Psychiatr Pract"},{"issue":"6","key":"1_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/PRA.0000000000000274","volume":"23","author":"S Preskorn","year":"2017","unstructured":"Preskorn S. CNS drug development, lessons learned, part 4: the role of brain circuitry and genes \u2013 tasimelteon as an example. J Psychiatr Pract. 2017b;23(6):425\u201330.","journal-title":"J Psychiatr Pract"},{"key":"1_CR11","volume-title":"Drug-drug interactions with an emphasis on psychiatric medications","author":"S Preskorn","year":"2018","unstructured":"Preskorn S. Drug-drug interactions with an emphasis on psychiatric medications. West Islip: Professional Communications, Inc; 2018."},{"issue":"3","key":"1_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/00131746-200205000-00006","volume":"8","author":"SH Preskorn","year":"2002","unstructured":"Preskorn SH, Baker B. The overlap of DSM-IV syndromes: potential implications for the practice of polypsychopharmacology, psychiatric drug development and the human genome project. J Psychiatr Pract. 2002;8(3):170\u20137.","journal-title":"J Psychiatr Pract"}],"container-title":["Advances in Neurobiology","Drug Development in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-21054-9_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T13:03:11Z","timestamp":1678971791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-21054-9_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031210532","9783031210549"],"references-count":12,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-21054-9_1","relation":{},"ISSN":["2190-5215","2190-5223"],"issn-type":[{"type":"print","value":"2190-5215"},{"type":"electronic","value":"2190-5223"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"17 March 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}